trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Rhabdoid Tumor D018335 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Ganglioneuroma D005729 2 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Park H et al. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. 2008 Int. J. Mol. Med. pmid:18949380
Lin YC et al. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. 2008 Brain Res. pmid:18950606
Haffner I et al. Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway. 2008 J. Cell. Biochem. pmid:17577214
Björkman M et al. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. 2008 Int. J. Cancer pmid:18798265
Oger F et al. The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni. 2008 Biochem. Biophys. Res. Commun. pmid:18977200
Albertus DL et al. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. 2008 J Thorac Oncol pmid:18978557
Chou CW and Chen CC HDAC inhibition upregulates the expression of angiostatic ADAMTS1. 2008 FEBS Lett. pmid:19007777
Setiadi AF et al. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. 2008 Cancer Res. pmid:19047136
Mizumoto S et al. The developmental potential of parthenogenetic and somatic cell nuclear-transferred rat oocytes in vitro. 2008 Cloning Stem Cells pmid:19049415
Slack MD et al. Characterizing heterogeneous cellular responses to perturbations. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:19052231
Chittur SV et al. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism. 2008 BMC Genomics pmid:18959802
Hayashi K et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. 2008 Cell Stem Cell pmid:18940731
Ridolfi E et al. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. 2008 Br. J. Cancer pmid:18941460
Cao W et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. 2008 J. Exp. Med. pmid:18504304
Bigl M et al. Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer. 2008 Biochem. Biophys. Res. Commun. pmid:18938139
Ramirez T et al. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. 2008 Chromosoma pmid:17999076
Zhang S et al. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. 2008 Exp. Oncol. pmid:19112422
Malinen M et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. 2008 Nucleic Acids Res. pmid:17999998
Kim TY et al. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. 2008 Exp. Mol. Med. pmid:19116449
Schäfer S et al. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). 2008 Bioorg. Med. Chem. pmid:18054239
Jiang SJ et al. [Effects of trichostatin A and paclitaxel on apoptosis and microtubule stabilization in endometrial carcinoma cells: an in vitro research]. 2008 Zhonghua Yi Xue Za Zhi pmid:19087722
Shi LH et al. Trichostatin A and nuclear reprogramming of cloned rabbit embryos. 2008 J. Anim. Sci. pmid:18245503
Paris M et al. Histone deacetylase inhibitors: from bench to clinic. 2008 J. Med. Chem. pmid:18247554
Gupta MP et al. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. 2008 J. Biol. Chem. pmid:18250163
Politis PK et al. BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells. 2008 FEBS Lett. pmid:18258204
Isakov E et al. Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica. 2008 Mol. Biochem. Parasitol. pmid:18191469
Andrews KT et al. Potent antimalarial activity of histone deacetylase inhibitor analogues. 2008 Antimicrob. Agents Chemother. pmid:18212103
Heller G et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. 2008 Cancer Res. pmid:18172295
Yildirim F et al. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. 2008 Exp. Neurol. pmid:18234195
Tang Y et al. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. 2008 Circ. Res. pmid:18239137
Wang Q et al. The spatial relationship between heterochromatin protein 1 alpha and histone modifications during mouse oocyte meiosis. 2008 Cell Cycle pmid:18239470
Balakrishnan L and Milavetz B HDAC inhibitors stimulate viral transcription by multiple mechanisms. 2008 Virol. J. pmid:18353181
Kimata Y et al. Diminishing HDACs by drugs or mutations promotes normal or abnormal sister chromatid separation by affecting APC/C and adherin. 2008 J. Cell. Sci. pmid:18354085
Suuronen T et al. Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. 2008 Neurochem. Res. pmid:18307035
Dalgard CL et al. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. 2008 Clin. Cancer Res. pmid:18483379
Jiang Y et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. 2008 J. Exp. Biol. pmid:18310117
Egler V et al. Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death. 2008 Clin. Cancer Res. pmid:18483381
Dong G et al. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. 2008 J. Pharmacol. Exp. Ther. pmid:18310471
Chen Y et al. A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. 2008 J. Med. Chem. pmid:18494463
Kim M et al. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. 2008 Mol. Cancer Res. pmid:18314483
Sun C and Zhou J Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. 2008 Biochem. Pharmacol. pmid:18495085
Schuetz A et al. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. 2008 J. Biol. Chem. pmid:18285338
Ma P and Schultz RM Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. 2008 Dev. Biol. pmid:18501342
Horswill MA et al. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. 2008 Exp. Eye Res. pmid:18291368
Chung KS et al. Fission yeast-based screening to identify putative HDAC inhibitors using a telomeric reporter strain. 2008 Mol. Cells pmid:18525239
Countryman JK et al. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. 2008 J. Virol. pmid:18337569
Makki MS et al. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. 2008 Nucleic Acids Res. pmid:18535006
Borghol N et al. Transcriptional and epigenetic status of protamine 1 and 2 genes following round spermatids injection into mouse oocytes. 2008 Genomics pmid:18343090
Hoffmann K et al. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? 2008 Epilepsy Res. pmid:18538545
Jiang X et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. 2008 Cancer Cell pmid:18538736
Gavin DP et al. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. 2008 Schizophr. Res. pmid:18539439
Lecona E et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. 2008 Mol. Cell. Biol. pmid:18541673
Wu X et al. Trichostatin A improved epigenetic modifications of transfected cells but did not improve subsequent cloned embryo development. 2008 Anim. Biotechnol. pmid:18855246
Li J et al. High in vitro development after somatic cell nuclear transfer and trichostatin A treatment of reconstructed porcine embryos. 2008 Theriogenology pmid:18573521
Karantzali E et al. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. 2008 Genome Biol. pmid:18394158
Ree AH et al. HDAC2 deficiency and histone acetylation. 2008 Nat. Genet. pmid:18583969
Galiová G et al. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. 2008 Eur. J. Cell Biol. pmid:18396346
Liu Y et al. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. 2008 Cancer Invest. pmid:18584348
Geli J et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. 2008 Int. J. Cancer pmid:18452173
Nakao Y et al. Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. 2008 Bioorg. Med. Chem. Lett. pmid:18397826
Mazitschek R et al. Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. 2008 Bioorg. Med. Chem. Lett. pmid:18430569
Chen PC et al. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. 2008 Bioorg. Med. Chem. pmid:18397827
Kim B et al. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. 2008 Eur. J. Pharmacol. pmid:18550052
Habold C et al. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. 2008 J. Cell. Mol. Med. pmid:18419600
Yan C et al. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors. 2008 Proteins pmid:18398905
Tavera-Mendoza LE et al. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18550844
Romieu P et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. 2008 J. Neurosci. pmid:18799668
Ko JM et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. 2008 Mol. Cancer Res. pmid:18403638
Lee TB et al. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy. 2008 BMC Gastroenterol pmid:18673531
Chan DW et al. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. 2008 Int. J. Cancer pmid:18553387
Roy S et al. Histone deacetylase 5 represses the transcription of cyclin D3. 2008 J. Cell. Biochem. pmid:18404677
Xiang N et al. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. 2008 Carcinogenesis pmid:18676679
Kawamoto K et al. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. 2008 Int. J. Cancer pmid:18404682
Northrop JK et al. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. 2008 J. Immunol. pmid:18606637
Kaipparettu BA et al. Estrogen-mediated downregulation of CD24 in breast cancer cells. 2008 Int. J. Cancer pmid:18404683
Schmeck B et al. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. 2008 J. Immunol. pmid:18606645
Jeseta M et al. In vitro ageing of pig oocytes: effects of the histone deacetylase inhibitor trichostatin A. 2008 Zygote pmid:18405435
Miyanaga A et al. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model. 2008 Mol. Cancer Ther. pmid:18606719
Lin YC et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. 2008 Cancer Res. pmid:18381445
Tischler JL et al. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors. 2008 J Enzyme Inhib Med Chem pmid:18608778
Chu F et al. Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. 2008 Aging Cell pmid:18489729
Wu JY et al. Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. 2008 Neuroreport pmid:18628666
Shakèd M et al. Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. 2008 PLoS ONE pmid:18628975
Su RC et al. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. 2008 J. Allergy Clin. Immunol. pmid:17980413
Yu J et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. 2008 Hepatology pmid:18666234
Iacobazzi V et al. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. 2008 Biochem. Biophys. Res. Commun. pmid:18706393
Falk M et al. Chromatin structure influences the sensitivity of DNA to gamma-radiation. 2008 Biochim. Biophys. Acta pmid:18706456
Schauber J et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. 2008 J. Invest. Dermatol. pmid:17943182
Zhang XH et al. Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer. 2008 Cancer Biol. Ther. pmid:18708766
Chen J et al. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. 2008 Chem. Biol. Interact. pmid:17961528
Yang YN et al. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells]. 2008 Ai Zheng pmid:18710614
Obrdlik A et al. The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription. 2008 Mol. Cell. Biol. pmid:18710935
Haumaitre C et al. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. 2008 Mol. Cell. Biol. pmid:18710955
Kim M et al. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. 2008 Cancer Res. pmid:18757430
Ma Y et al. Inhibition of protein deacetylation by trichostatin A impairs microtubule-kinetochore attachment. 2008 Cell. Mol. Life Sci. pmid:18759129
Zhang Y et al. Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. 2008 J. Immunol. pmid:18097041
Jin B et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. 2008 Hum. Mol. Genet. pmid:18029387
Gan Y et al. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. 2008 Biochem. Biophys. Res. Commun. pmid:17996726
Lee EJ et al. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. 2008 Int. J. Oncol. pmid:18813790
Van Wagoner DR and Nattel S Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. 2008 J. Mol. Cell. Cardiol. pmid:18817781